Avricore Health Inc.

AVCR

CA0545211090

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 12:28:14 2024-04-24 pm EDT			5-day change	1st Jan Change
0.14 ^CAD	-6.67%		0.00%	-17.65%

Apr. 04	Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	MT
2023	Avricore Health Provides Update on Q3	MT

Avricore Health Inc. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2020

July 08, 2021 at 03:02 pm EDT

Avricore Health Inc. announced audited consolidated earnings results for the year ended December 31, 2020. The company reported revenue of CAD 33,030 against CAD 33,000 a year ago. Net loss and comprehensive loss for the period was CAD 1,173,966 against CAD 2,105,608 a year ago. Basic and diluted loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.

Latest news about Avricore Health Inc.

Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	Apr. 04	MT
Avricore Health Provides Update on Q3	Nov. 30	MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab	23-09-15	CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland	23-08-08	MT
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One	23-08-03	CI
HealthTab to Integrate CONTOUR NEXT Family of Blood Glucose Meters For Deeper Diabetes Patient Insights	23-07-19	MT
Avricore Health Inc Announces Agreement with Ascensia Diabetes Cares	23-07-19	CI
Avricore Health Inc. Announces Board Changes	23-06-21	CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt	23-04-30	CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection	23-03-23	MT
Avricore Health Provides Update	23-02-01	MT
Avricore Health Expands the Number of Shoppers Drug Mart Pharmacies Offering Its HealthTab Point-Of-Care Testing Platform Under A Renewed Master Service Agreement	23-01-06	CI
Avricore Health Reports Q3 Results	22-11-29	MT
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Avricore Health Inc. Expands with Shoppers Drug Mart®	22-08-08	CI
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
Avricore Health Inc. Auditor Raises 'Going Concern' Doubt	22-04-21	CI
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-21	CI
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
Avricore Health to Offer Abbott Test to Select Community Pharmacies in Canada	21-11-23	MT

Chart Avricore Health Inc.

Duration

Period

More charts

Company Profile

Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AVRICORE HEALTH INC.	-17.65%	10.19M
ELI LILLY AND COMPANY	+25.61%	660B
NOVO NORDISK A/S	+25.87%	562B
JOHNSON & JOHNSON	-5.24%	358B
MERCK & CO., INC.	+16.49%	322B
ABBVIE INC.	+8.28%	297B
ASTRAZENECA PLC	+7.09%	219B
ROCHE HOLDING AG	-9.12%	196B
NOVARTIS AG	+5.01%	199B
PFIZER, INC.	-8.75%	149B